SGX523 Capsules

DRUG2 trials

Sponsors

SGX Pharmaceuticals, Inc.

Conditions

Advanced Cancer

Phase 1

Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors

TerminatedNCT00607399

SGX Pharmaceuticals, Inc.Advanced Cancer

Start: 2008-01-31End: 2009-06-30Target: 46Updated: 2008-07-24

Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors

TerminatedNCT00606879

SGX Pharmaceuticals, Inc.Advanced Cancer

Start: 2008-01-31End: 2009-06-30Target: 46Updated: 2008-07-24